journal article·2020-02Open access

Post-production modifications of murine mesenchymal stem cell (mMSC) derived extracellular vesicles (EVs) and impact on their cellular interaction

Sarah Le Saux, Hanna Aarrass, Joséphine Lai-Kee-Him, Patrick Bron, Jean Armengaud, Guylaine Miotello, Justine Bertrand-Michel, Emeric Dubois, Simon George, Orestis Faklaris, Jean-Marie Devoisselle, Philippe Legrand, Joël Chopineau, Marie Morille

Biomaterials· Volume 231

Abstract

In regards to their key role in intercellular communication, extracellular vesicles (EVs) have a strong potential as bio-inspired drug delivery systems (DDS). With the aim of circumventing some of their well-known issues (production yield, drug loading yield, pharmacokinetics), we specifically focused on switching the biological vision of these entities to a more physico-chemical one, and to consider and fine-tune EVs as synthetic vectors. To allow a rational use, we first performed a full physico-chemical (size, concentration, surface charge, cryoTEM), biochemical (western blot, proteomics, lipidomics, transcriptomics) and biological (cell internalisation) characterisation of murine mesenchymal stem cell (mMSC)-derived EVs. A stability study based on evaluating the colloidal behaviour of obtained vesicles was performed in order to identify optimal storage conditions. We evidenced the interest of using EVs instead of liposomes, in regards to target cell internalisation efficiency. EVs were shown to be internalised through a caveolae and cholesterol-dependent pathway, following a different endocytic route than liposomes. Then, we characterised the effect of physical methods scarcely investigated with EVs (extrusion through 50 nm membranes, freeze-drying, sonication) on EV size, concentration, structure and cell internalisation properties. Our extensive characterisation of the effect of these physical processes highlights their promise as loading methods to make EVs efficient delivery vehicles.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (91)

Show source-provided references
1. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy
2. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins10.1016/j.jconrel.2014.11.029 ↗
3. Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle10.2147/OTT.S173110 ↗
4. Shedding light on the cell biology of extracellular vesicles10.1038/nrm.2017.125 ↗
5. Extracellular vesicle docking at the cellular port: extracellular vesicle binding and uptake10.1016/j.semcdb.2017.01.002 ↗
6. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer10.1038/nature22341 ↗
7. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes10.1038/nbt.1807 ↗
8. Strategic design of extracellular vesicle drug delivery systems10.1016/j.addr.2018.06.017 ↗
9. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain10.1038/mt.2011.164 ↗
10. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles10.1016/j.jconrel.2013.08.014 ↗
11. Exosomes as drug delivery vehicles for Parkinson's disease therapy10.1016/j.jconrel.2015.03.033 ↗
12. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells10.1016/j.nano.2015.10.012 ↗
13. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines10.1080/20013078.2018.1535750 ↗
14. Good things come in small packages: overcoming challenges to harness extracellular vesicles for therapeutic delivery10.1016/j.jconrel.2016.09.016 ↗
15. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes10.3402/jev.v1i0.18396 ↗
16. Mesenchymal stem cell derived exosomes in cancer progression, metastasis and drug delivery: a comprehensive review10.7150/jca.25376 ↗
17. A new approach for loading anticancer drugs into mesenchymal stem cell-derived exosome mimetics for cancer therapy10.3389/fphar.2018.01116 ↗
18. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease10.1038/leu.2014.41 ↗
19. Extracellular vesicles protect glucuronidase model enzymes during freeze-drying10.1038/s41598-018-30786-y ↗
20. Tripartite polyionic complex (PIC) micelles as non-viral vectors for mesenchymal stem cell siRNA transfection10.1039/C7BM00384F ↗
21. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy
22. Liposomal formulations in clinical use: an updated review10.3390/pharmaceutics9020012 ↗
23. Taking the shortcut for high-throughput shotgun proteomic analysis of bacteria10.1007/978-1-4939-1261-2_16 ↗
24. RNA-binding proteins are a major target of silica nanoparticles in cell extracts10.1080/17435390.2016.1244299 ↗
25. A rapid method of total lipid extraction and purification10.1139/o59-099 ↗
26. Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases10.1016/S0021-9258(19)78162-9 ↗
27. LC-MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites10.1016/j.jchromb.2013.06.014 ↗
28. Cutadapt removes adapter sequences from high-throughput sequencing reads
29. miARma-Seq: a comprehensive tool for miRNA, mRNA and circRNA analysis10.1038/srep25749 ↗
30. Bioconductor: open software development for computational biology and bioinformatics10.1186/gb-2004-5-10-r80 ↗
31. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data10.1093/bioinformatics/btp616 ↗
32. Differential expression analysis for sequence count data10.1186/gb-2010-11-10-r106 ↗
33. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq210.1186/s13059-014-0550-8 ↗
34. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes10.1073/pnas.1521230113 ↗
35. Oncosomes - large and small: what are they, where they came from?10.3402/jev.v5.33109 ↗
36. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection10.1016/j.biocel.2012.06.018 ↗
37. Tetraspanin functions and associated microdomains10.1038/nrm1736 ↗
38. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain10.1146/annurev.cellbio.19.111301.153609 ↗
39. PatternLab for proteomics: a tool for differential shotgun proteomics10.1186/1471-2105-9-316 ↗
40. Cystamine-terminated poly(beta-amino ester)s for siRNA delivery to human mesenchymal stem cells and enhancement of osteogenic differentiation10.1016/j.biomaterials.2012.07.036 ↗
41. TGF-beta1 induces a nucleus pulposus-like phenotype in Notch 1 knockdown rabbit bone marrow mesenchymal stem cells10.1002/cbin.10109 ↗
42. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling10.4161/rna.8.5.16043 ↗
43. Extracellular vesicles: unique intercellular delivery vehicles10.1016/j.tcb.2016.11.003 ↗
44. Focus on mesenchymal stem cell-derived exosomes: opportunities and challenges in cell-free therapy
45. Interaction and uptake of exosomes by ovarian cancer cells10.1186/1471-2407-11-108 ↗
46. High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources10.3402/jev.v5.32570 ↗
47. 2017
48. Lipids in exosomes: current knowledge and the way forward10.1016/j.plipres.2017.03.001 ↗
49. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells10.1016/j.bbalip.2013.04.011 ↗
50. Ceramide triggers budding of exosome vesicles into multivesicular endosomes10.1126/science.1153124 ↗
51. Proteomic and biochemical analyses of human B cell-derived exosomes - potential implications for their function and multivesicular body formation10.1074/jbc.M207550200 ↗
52. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization10.1042/bj20031594 ↗
53. Asymmetric distribution of phospholipids in the membrane of vesicles released during in vitro maturation of Guinea pig reticulocytes: evidence precluding a role for "aminophospholipid translocase10.1002/jcp.1041400308 ↗
54. The ether lipid precursor hexadecylglycerol stimulates the release and changes the composition of exosomes derived from PC-3 cells10.1074/jbc.M114.593962 ↗
55. Distinct lipid compositions of two types of human prostasomes10.1002/pmic.201200348 ↗
56. Extracellular vesicles: lipids as key components of their biogenesis and functions10.1194/jlr.E086173 ↗
57. miR-10a restores human mesenchymal stem cell differentiation by repressing KLF410.1002/jcp.24402 ↗
58. Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression10.1089/scd.2012.0014 ↗
59. microRNA-10b promotes the migration of mouse bone marrow-derived mesenchymal stem cells and downregulates the expression of E-cadherin10.3892/mmr.2013.1615 ↗
60. The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-14310.1002/stem.1543 ↗
61. Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species10.1186/s13287-015-0116-z ↗
62. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth10.1016/j.canlet.2013.02.019 ↗
63. MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma10.3109/07357907.2010.512596 ↗
64. microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA210.1002/jcp.28747 ↗
65. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells10.1371/journal.pone.0084256 ↗
66. Exosomal miR-223 contributes to mesenchymal stem cell-elicited cardioprotection in polymicrobial sepsis10.1038/srep13721 ↗
67. Shao · 2017
68. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-2210.1371/journal.pone.0088685 ↗
69. Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles10.1371/journal.pone.0073304 ↗
70. MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction
71. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
72. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles10.1038/ncomms2282 ↗
73. Influence of storage condition on exosome recovery10.1007/s12257-015-0781-x ↗
74. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma10.1002/pmic.201300282 ↗
75. Trehalose prevents aggregation of exosomes and cryodamage10.1038/srep36162 ↗
76. Preservation of exosomes at room temperature using lyophilization10.1016/j.ijpharm.2018.10.032 ↗
77. Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid10.3233/CBM-160609 ↗
78. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery10.1016/j.addr.2016.01.022 ↗
79. Lipid nanoparticle delivery systems for siRNA-based therapeutics10.1007/s13346-013-0161-z ↗
80. Routes and mechanisms of extracellular vesicle uptake10.3402/jev.v3.24641 ↗
81. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells10.1182/blood-2004-03-0824 ↗
82. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes10.1182/blood-2011-02-338004 ↗
83. Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-110.1074/jbc.M112.445403 ↗
84. Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway10.1182/blood-2008-05-158642 ↗
85. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection10.1016/j.jbiotec.2013.03.013 ↗
86. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes10.1016/j.jconrel.2014.12.013 ↗
87. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting10.3402/jev.v4.26316 ↗
88. Quantitative analysis of tissue distribution of the B16bl6-derived exosomes using a streptavidin-lactadherin fusion protein and iodine-125-labeled biotin derivative after intravenous injection in mice10.1002/jps.24251 ↗
89. Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting10.3402/jev.v5.31053 ↗
90. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time10.1016/j.jconrel.2016.01.009 ↗
91. Surface functionalization of exosomes using click chemistry10.1021/bc500291r ↗